scorecardresearch
Add as a preferred source on Google
Thursday, September 10, 2026
Celebrating 9 Years
Support Our Journalism
Home Authors Posts by Sneha Richhariya

Sneha Richhariya

166 POSTS
Air pollution linked to millions of cancer cases globally. How it can damage more than just lungs

Air pollution linked to millions of cancer cases globally. How it can damage more than just lungs

Sneha Richhariya -
No need to panic over H1N1 surge, most cases mild and no new strain—ICMR DG Rajiv Bahl

No need to panic over H1N1 surge, most cases mild and no new strain—ICMR DG Rajiv Bahl

Sneha Richhariya -
US FDA clears Roche-Lilly single-biomarker blood test that helps check for Alzheimer’s-linked changes

US FDA clears Roche-Lilly single-biomarker blood test that helps check for Alzheimer’s-linked changes

Sneha Richhariya -
Robot-assisted knee surgery more precise but no better patient outcomes at one year, UK trial finds

Robot-assisted knee surgery more precise but no better patient outcomes at one year, UK trial finds

Sneha Richhariya -
Generic lenacapavir for HIV prevention moves closer to India with CDSCO waiver of local Phase 3 trials

Generic lenacapavir for HIV prevention moves closer to India with CDSCO waiver of local Phase 3 trials

Sneha Richhariya -
No new H1N1 strain in India, but children & elderly at higher risk, say ICMR scientists

No new H1N1 strain in India, but children & elderly at higher risk, say ICMR scientists

Sneha Richhariya -
Swine flu surge fills OPDs. Doctors across cities flag severe cases in unvaccinated, vulnerable groups

Swine flu surge fills OPDs. Doctors across cities flag severe cases in unvaccinated, vulnerable groups

Sneha Richhariya -
Discarded donor corneas could get a new life. How AIIMS trial can ease India’s cornea shortage

Discarded donor corneas could get a new life. How AIIMS trial can ease India’s cornea shortage

+TFP
Sneha Richhariya -
Merck-Moderna mRNA vaccine cuts risk of melanoma returning or spreading in Phase 3 trial. How it works

Merck-Moderna mRNA vaccine cuts risk of melanoma returning or spreading in Phase 3 trial. How it works

Sneha Richhariya -
‘Just scratching the surface’: How Ozempic maker Novo Nordisk sees India’s GLP-1 market growing

‘Just scratching the surface’: How Ozempic maker Novo Nordisk sees India’s GLP-1 market growing

Sneha Richhariya -
123...17Page 2 of 17

Follow us

Copyright © 2026 Printline Media Pvt. Ltd. All rights reserved.